Research in Vestibular Science

Review Articles

Multimodal diagnostic evaluation in Ménière disease: a narrative review of vestibular function tests and gadoliniumenhanced magnetic resonance imaging for endolymphatic hydrops: Tae Hoon Kong, Young Joon Seo; Res Vestib Sci. 2025;24(4):205-214. Published online December 15, 2025; DOI: https://doi.org/10.21790/rvs.2025.014

1,106 View
97 Download

Abstract PDF: Objectives
Ménière disease (MD) is a complex inner ear disorder marked by episodic vertigo, fluctuating hearing loss, and tinnitus. Despite established clinical diagnostic criteria, definitive diagnosis remains challenging due to symptom overlap and lack of objective biomarkers. This review examines the diagnostic utility of advanced vestibular function tests (VFTs)—caloric testing, video head impulse test (vHIT), vestibular evoked myogenic potentials (VEMPs), and rotatory chair testing—alongside three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) magnetic resonance imaging (MRI) imaging of endolymphatic hydrops (EHs). We propose an integrated diagnostic model that improves sensitivity, specificity, and clinical decision-making.
Methods
Evidence from recent cohort studies, meta-analyses, and high-resolution MRI protocols is synthesized. Sensitivity, specificity, and functional target profiles are compared across modalities. Test concordance and discordance patterns are reviewed, and a stratified risk algorithm is presented.
Results
Triple test concordance (caloric+vHIT+cervical VEMP [cVEMP]) provides 78% sensitivity and 92% specificity for definite MD. Gadolinium-enhanced 3D-FLAIR MRI detects cochlear EHs with sensitivities reported up to 95% and specificities commonly ranging from 85% to 90%, while vestibular hydrops detection shows comparatively lower sensitivity across studies. In our synthesis, combined strategies—operationalized as triple vestibular testing (caloric+vHIT+cVEMP) with selective MRI when indicated—improve overall diagnostic performance relative to single-modality testing (65% with a single test to 88% to 90% when ≥2 VFTs are abnormal, and MRI corroborates hydrops).
Conclusions
Multimodal assessment may serve as an objective adjunct to clinical criteria. In practice, we use MRI selectively—for atypical or refractory cases, or when VFTs are inconclusive—to complement the stepwise diagnostic pathway.

Dissecting the genome in Ménière disease: a review: Mai T. Pham, Pablo Cruz-Granados, Jose A. Lopez-Escamez; Res Vestib Sci. 2025;24(3):139-152. Published online September 15, 2025; DOI: https://doi.org/10.21790/rvs.2025.010

2,965 View
67 Download

Abstract PDF: Ménière disease (MD) is a complex inner ear disorder characterized by episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. Despite its prevalence across European and Asian populations, along with five clinical subtypes with variable phenotypes and comorbidities, the molecular underpinnings of MD pathogenesis remain under investigation. This review aims to comprehensively summarize the genomic, epigenomic, and transcriptomic insights into MD, highlighting how these molecular layers contribute to disease susceptibility, progression, and phenotypic variability. Sporadic MD accounts for most diagnoses, where multifactorial mechanisms involving pathogenic rare variants, epigenetic modifications, and immune-related pathways contribute to disease risk. We also elucidate the genetic contribution of familial MD, in which inherited variants, primarily in genes involved in the extracellular structures of sensory epithelia and the stereocilia links of sensory cells, contribute to autosomal dominant, recessive, or digenic inheritance models. Furthermore, we explore the current use of animal models in validating gene pathogenicity. By integrating findings across multi-omics studies, this review emphasizes that MD is a polygenic and heterogeneous inherited disorder, with a spectrum of related conditions with common and distinct molecular origins. Understanding molecular mechanisms involving genetic and epigenetic factors is promising for biomarker discovery and future therapeutic interventions.

Surgical treatment of vestibular disorders: a narrative review: Ja-Won Koo, Jung Kyu Lee, Dong Woo Nam; Res Vestib Sci. 2025;24(3):177-188. Published online September 15, 2025; DOI: https://doi.org/10.21790/rvs.2025.007

3,191 View
43 Download

Abstract PDF: Since most vestibular disorders are controlled by medical treatments, surgical options are rarely required. However, there are several vestibular lesions in which surgery can fix the underlying pathophysiology, or should be considered when patients do not benefit from medical treatments. Those diagnoses are labyrinthine fistula, perilymphatic fistula, superior semicircular canal dehiscence syndrome, vestibular paroxysms, rotational vertebral artery syndrome, refractory benign paroxysmal positional vertigo, and intractable Ménière disease. Many surgical options may produce irreversible changes in the vestibular system as well as hearing function. So, accurate diagnosis is paramount for appropriate treatment. In addition, a thorough understanding of disease pathology and the natural course of the condition are essential, as are the experience and judgment of the surgeon, which significantly influence treatment outcomes. Also, it should be noted that surgical procedures are not always successful in controlling vertigo or dizziness. Except in cases of dizziness caused by tumors or inner ear fistula, the role of surgery in treating vestibular disorders is primarily to control symptoms rather than to eliminate the underlying disease. Therefore, most patients should be managed surgically only when medical treatments fail or when surgery is deemed more effective. Before proceeding, patients must fully understand the surgical objectives, potential outcomes, and possible complications. This review provides surgical options for vestibular disorders, emphasizing accurate diagnosis, patient-centered decision-making, and the potential risks of each surgical procedure.

Original Articles

Prevalence and preferred medication for vestibular migraine in Menière’s disease: a multicenter retrospective cohort study in Korea: Dong-Han Lee, Hong Ju Park, Kyu-Sung Kim, Hyun Ji Kim, Jae-Yong Byun, Min-Beom Kim, Minbum Kim, Myung-Whan Suh, Jae-Hyun Seo, Jong Dae Lee, Eun-Ju Jeon, Myung Hoon Yoo, Seok Min Hong, Sung-Kwang Hong, Hyo-Jeong Lee, Jung Woo Lee, Se-Joon Oh, Hyun Ah Kim, Hyung Lee, Eek-Sung Lee, Eun-Jin Kwon, Seong-Hae Jeong, Jeong-Yoon Choi, Chang-Hee Kim; Res Vestib Sci. 2024;23(2):37-45. Published online June 14, 2024; DOI: https://doi.org/10.21790/rvs.2024.005

4,668 View
88 Download

Abstract PDF Supplementary Material: Objectives
The aim of this study is to categorize headaches associated with definite Menière’s disease (MD) according to diagnostic criteria, to determine their prevalence, and to investigate the preferred medication across participating centers.
Methods
Patients diagnosed with definite MD at 17 university hospitals in otolaryngology or neurology departments in Korea between January 1, 2021 to December 31, 2021 were retrospectively included. Data on the presence of accompanying vestibular migraine (VM), migraine or non-migraine headaches, and clinical information were collected. A survey was conducted to assess preferences for treatment drugs for vertigo and headache control in MD patients with headache.
Results
A total of 435 definite MD patients were included, with a mean age of 57.0±14.9 years. Among them, 135 (31.0%) had accompanying headaches, of whom 48 (11.0% of all definite MD patients) could be diagnosed with VM. The prevalence of comorbid VM (definite and probable) was significantly higher in females (41 of 288, 14.2%) than in males (7 of 147, 4.8%) (p<0.05). There was no significant difference in the prevalence of comorbid VM between unilateral and bilateral MD patients (10.8% and 13.6%, respectively) (p > 0.05). Benzodiazepines, antihistamines, and antiemetics were mainly preferred for acute vertigo control, while nonsteroidal anti-inflammatory drugs, acetaminophen, and triptans were preferred for acute headache control, and topiramate, propranolol, and calcium channel blockers were mainly preferred for headache prevention.
Conclusions
VM is not uncommon in patients with definite MD in Korea. Further research is needed to understand the differences in headache prevalence and preferred medications across different centers.

Clinical Outcomes of Endolymphatic Sac Decompression Surgery in Menière’s Disease: Hee Won Seo, Young Sang Cho, Won-Ho Chung; Res Vestib Sci. 2023;22(4):97-105. Published online December 15, 2023; DOI: https://doi.org/10.21790/rvs.2023.22.4.97

10,727 View
106 Download

Abstract PDF: Objectives
Endolymphatic sac decompression surgery (ESDS) is one of the surgical methods for intractable Menière’s disease (MD), and it is known as a relatively safe treatment that does not cause hearing loss. However, the effectiveness and the degree of vertigo control rate of ESDS are still controversial. In this study, we aimed to evaluate the clinical outcomes of ESDS in intractable MD.
Methods
We retrospectively reviewed 33 patients who underwent ESDS for intractable MD from January 2002 to March 2022. Clinical characteristics of patients, pure tone threshold, medical treatment method, and number of vertigo attacks before and after surgery were assessed. The improvement of hearing and vertigo was evaluated according to the 1995 American Academy of Otolaryngology-Head and Neck Surgery criteria.
Results
Of the 33 patients, the average follow-up period was 21.2 months, with immediate follow-up within 2 months (28 patients), short term between 2 and 6 months (27 patients), and long term at 12 months or later (29 patients). In the immediate hearing threshold, both air conduction and bone conduction showed slight deterioration, but there was no significant change in the long-term hearing threshold. At long-term follow-up, 12 patients (41.4%) were able to live without medication, and 18 patients (62.1%) showed improvement in their vertigo symptoms. In addition, patients who showed improvement in hearing also showed improvement in vertigo at the same time.
Conclusions
ESDS in intractable MD is a relatively safe and effective treatment method for reducing vertigo attack without worsening hearing threshold.

Comparison of Predictive Parameters between the Video Head Impulse Test and Caloric Test: Chun Han, Seung Won Paik, Hui Joon Yang, Sang Yoo Park, Ji Hyeon Lee, Young Joon Seo; Res Vestib Sci. 2020;19(2):55-61. Published online June 15, 2020; DOI: https://doi.org/10.21790/rvs.2020.19.2.55

9,957 View
131 Download
1 Crossref

Abstract PDF

Objectives
The aim of this paper was to determine if a correlation exists between video head impulse test (vHIT) and electronystagmography with caloric test (ENG). More specifically, comparison of covert and overt value from vHIT test with cold and warm stimulation value from ENG test.
Methods
Retrospective study of our single institue from the period of January 2015 to January 2017 enrolled 91 patients. Patients were divided into 3 groups by their diagnosis of either vestibular neuritis (VN), Meniere disease, or sudden sensorineural loss with vertigo accordingly. Each of the patients’ both ENG and vHIT data were recorded and parameters were evaluated.
Results
VN group was the only group to show a significant correlation between canal paresis (CP) with covert and overt saccades. Further analysis was done in the VN group and result showed covert saccade showing a larger area under the receiver operation characteristic curve value (0.77) compared to overt saccades (0.70), implying that covert saccade is a more accurate parameter for the prediction of the CP value. Furthermore, a positive correlation was seen between the gain value and the cold caloric stimulation value as well as between warm caloric stimulation value.
Conclusions
The value of our study lies in the fact that we have attempted to find a correlation between different parameters of 2 different vestibular tests. We concluded that the evaluation of overt nystagmus by the bedside head thrust test is inappropriate for predicting CP, and a vHIT is required to accurately evaluate vestibular function.

Citations

Citations to this article as recorded by

A Comparative Analysis of the Vestibulocochlear Function in Patients with Isolated Semicircular Canal Hypofunction Using a Video Head Impulse Test
Yu Jung Park, Min Young Lee, Ji Eun Choi, Jae Yun Jung, Jung Hwa Bahng
Research in Vestibular Science.2023; 22(2): 34. CrossRef

Incidence of Progression into Ménière Disease from Idiopathic Sudden Sensorineural Hearing Loss: Midterm Follow-up Study: Byeong Min Lee, Jin Hyun Seo, Hyun Woo Park, Hyun Jin Lee, Dong Gu Hur, Seong Ki Ahn; Res Vestib Sci. 2018;17(3):95-101. Published online September 18, 2018; DOI: https://doi.org/10.21790/rvs.2018.17.3.95

7,753 View
206 Download

Abstract PDF: Objectives
Ménière disease is a clinical syndrome characterized by the four major symptoms of episodic vertigo, sensorineural hearing loss, tinnitus, and aural fullness. Sensorineural hearing loss, especially low frequency, is the characteristic type of audiogram in Ménière's disease. However, it is difficult to distinguish idiopathic sudden sensorineural hearing loss (ISSNHL) with vertigo from the first attack of Ménière disease. The purpose of this study was to investigate the incidence of progression into Ménière Disease from low frequency ISSNHL.
Methods
Two hundred eighty-three patients were included in this study. We classified the patients with ISSNHL according to the hearing loss in audiogram and analyzed how many of them actually progressed to Ménière disease based on diagnosis criteria.
Results
Among the 240 patients, 37.1% (89 patients) were confirmed low frequency ISSNHL and 14.6% (13 patients) of them were diagnosed with Meniere disease.
Conclusions
This study showed that the progression from low frequency ISSNHL to Ménière disease was higher than other frequency ISSNHL, as in other studies.

Prognosis of Sudden Low Frequency Hearing Loss during Long-term Follow-up: Ji Hyung Kim, Sang Hyun Kwak, Seong Hoon Bae, Sung Hunh Kim, Gi-Sung Nam; Res Vestib Sci. 2018;17(3):102-108. Published online September 18, 2018; DOI: https://doi.org/10.21790/rvs.2018.17.3.102

11,127 View
551 Download
1 Crossref

Abstract PDF

Objectives
The prognosis of sudden low frequency hearing loss (SLFHL) is relatively good, but recurrences of hearing loss and possible progression to Meniere’s disease is still a clinically important concern. This study was conducted to confirm the rate at which SLFHL proceeds to Meniere’s disease.
Methods
We retrospectively analyzed the medical records of 160 SLFHL patients who were followed up for more than 6 months from September 2005 to August 2013. Progression, initial hearing level, recovery and recurrence of hearing loss were reviewed.
Results
106 patients (66.25%) had complete hearing recovery, 32 (20%) had recurrent hearing loss. Of the 32 recurrent group, 15 (9.38%) had progressed to Meniere’s disease after average of 1.7±1.4 years. The mean age of nonrecurrent group was higher than recurrent group (55.3±14.6 and 48.0±13.4, respectively, p=0.011). The threshold of 250Hz was significantly higher in the nonrecurrent group compared with recurrent group (p=0.047).
Conclusions
In patients with SLFHL, recurrence at relatively young age should be considered with the possibility of progression to Meniere’s disease.

Citations

Citations to this article as recorded by

Findings of Intravenous Gadolinium Inner Ear Magnetic Resonance Imaging in Patients With Acute Low-Tone Sensorineural Hearing Loss
Hee Won Seo, Yikyung Kim, Hyung-Jin Kim, Won-Ho Chung, Young Sang Cho
Clinical and Experimental Otorhinolaryngology.2023; 16(4): 334. CrossRef

Hyper-response of Cervical Vestibular Evoked Myogenic Potential in Patients with Meniere Disease: A Preliminary Study: Soyeon Yoon, Mi Joo Kim, Minbum Kim; Res Vestib Sci. 2018;17(2):44-48. Published online June 15, 2018; DOI: https://doi.org/10.21790/rvs.2018.17.2.44

7,246 View
112 Download
2 Crossref

Abstract PDF

Objectives
The purpose of this study is to investigate the hyper-responsiveness of cervical vestibular-evoked myogenic potential (cVEMP) in patients with Meniere disease (MD), and to compare the result of cVEMP between probable and definite MD group.
Methods
A total of 110 patients satisfied with probable MD and definite MD criteria, which is recently formulated by the Classification Committee of the Bárány Society, were included. An interpeak amplitude and interaural amplitude difference (IAD) ratio of both ears was measured. The abnormal response of ipsi-lesional cVEMP was categorized into 2 groups; hyper-response and hypo-response. Chi-square test and Mann-Whitney U-test were used for statistical analysis.
Results
In the probable MD and definite MD group, the mean IAD was 25.24%±17.79% and 53.82%±34.98%, respectively (p＜0.01). The abnormal response of cVEMP at the affected ear was more frequent in the definite MD group, compared to the probable MD group (32/40 vs. 13/36, p＜0.01). However, hyper-response was more frequently observed in the patients with probable MD, compared to the patients with definite MD (13/36 vs. 3/40, p＜0.01).
Conclusion
Hyper-response of cVEMP was more frequently observed in the early probable MD patients. It might be an early sign of MD, related with the saccular hydrops, which can help the early detection and treatment.

Citations

Citations to this article as recorded by

Superior Semicircular Canal Dehiscence Syndrome Manifested as Menière’s Disease: A Case Report
Byeong Jin Kim, Yun Na Yang, Chan Mi Lee, Eun Jung Lee
Research in Vestibular Science.2021; 20(3): 108. CrossRef
Characteristics of Nystagmus during Attack of Vestibular Migraine
Soyeon Yoon, Mi Joo Kim, Minbum Kim
Research in Vestibular Science.2019; 18(2): 38. CrossRef

Case Report

A Case of Recurrent Vertigo in Vestibular Schwannoma Treated with Chemical Labyrinthectomy: Seung Jae Lee, Eun Sang Lee, Bo Gyung Kim, Jong Dae Lee; Res Vestib Sci. 2017;16(4):147-150. Published online December 15, 2017; DOI: https://doi.org/10.21790/rvs.2017.16.4.147

8,788 View
119 Download
1 Crossref

Abstract PDF

Vestibular schwannoma (VS) can have various symptoms and almost half of the patients have balance problems. Some patients with VS can suffer from recurrent vertigo mimicking Meniere’s disease. We present the case of a 61-year-old male patient who was suffering from recurrent vertigo due to VS while symptoms improved by chemical labyrinthectomy with gentamicin. We consider that chemical labyrinthectomy can be an option in the treatment of patients with recurrent vertigo for VS.

Citations

Citations to this article as recorded by

Diagnosis and Management of Vestibular Schwannoma: Focus on Dizziness
Sung Il Nam
Research in Vestibular Science.2021; 20(4): 119. CrossRef

Reviews

Recent Research Trend for Ménièreʼs Disease: Sung-Il Nam; Res Vestib Sci. 2017;16(2):39-46. Published online June 15, 2017; DOI: https://doi.org/10.21790/rvs.2017.16.2.39

9,283 View
258 Download

Abstract PDF: Ménièreʼs disease is a poorly understood disorder of the inner ear characterized by intermittent episodic vertigo, fluctuating hearing loss, ear fullness and tinnitus. In this paper, we present a review of the histopathology, cytochemistry, gene, blood-labyrinthine barrier and imaging of Ménièreʼs disease. Histopathology is significant for neuroepithelial damage with hair cell loss, basement membrane thickening, perivascular damage and microvascular damage. Cytochemical alterations are significant for altered AQP4 and AQP6 expression in the supporting cell, and altered cochlin and mitochondrial protein expression. Since the discovery of aquaporin water channels (AQP1, AQP2, AQP3, AQP4, AQP5, AQP6, AQP7 and AQP9), it has become clear that these channels play a crucial role in inner ear fluid homeostasis. Several gene studies related to Ménièreʼs disease have been published, but there is no clear evidence that Ménièreʼs disease is associated with a special gene. Currently, imaging techniques to determine the extent and presence of endolymphatic hydrops are being studied, and further studies are needed to correlate the visualization of the endolymphatic hydrops with clinical symptoms.

Experiemental Model for Ménière’s Disease Using Surgical Ablation of Endolymphatic Sac: Minbum Kim, Mi Joo Kim; Res Vestib Sci. 2016;15(4):95-100. Published online December 12, 2016; DOI: https://doi.org/10.21790/rvs.2016.15.4.95

12,229 View
160 Download

Abstract PDF: Endolymphatic hydrops is a representing pathologic finding of Ménière's disease. For the induction of endolymphatic hydrops in an animal model, surgical ablation of endolymphatic sac has been used. Although traditional model with the blockage of endolymphatic sac induced severe hydrops, it has several limitations for the study of pathophysiology of Ménière's disease. Recently, modified experimental models have been introduced, in which additional procedure was performed to induce the acute aggravation of hydrops after the surgical ablation. These new models could be helpful to elucidate the mechanism and develop a new treatment of Ménière's disease. In this review, we introduce the characteristics of animal models using surgical ablation of endolymphatic sac from the classical model to novel modified models.

Case Report

A Case of Patient with Meniere’s Disease Who Presented Periodic Alternating Nystagmus: Jin Woo Park, Ja Won Gu, Mee Hyun Song, Dae Bo Shim; Res Vestib Sci. 2016;15(3):80-83. Published online September 15, 2016; DOI: https://doi.org/10.21790/rvs.2016.15.3.80

9,418 View
120 Download

Abstract PDF: Periodic alternating nystagmus (PAN) is a spontaneous horizontal jerky nystagmus that reverses its direction periodically with a quiescent interval. PAN has been reported in acquired and congenital forms. The main lesion site of the acquired form of PAN has been attributed to the caudal brainstem or cerebellum. Herein we report a 63-year-old male patient with Meniere’s disease, who presented PAN during a vertigo attack. The patient demonstrated no abnormality on neurologic evaluation and brain imaging, which is different feature compared to the central or congenital form of PAN. It should be kept in mind that peripheral vestibular disorders such as Meniere’s disease can produce PAN.

Review

A History for Experimental Animal Models of Endolymphatic Hydrops: Hyun Ji Kim, Kyu-Sung Kim; Res Vestib Sci. 2016;15(3):65-69. Published online September 15, 2016; DOI: https://doi.org/10.21790/rvs.2016.15.3.65

8,998 View
190 Download

Abstract PDF: It is known that endolymphatic hydrops is a pathophysiologic mechanism of Meniere’s disease, while the detailed role is not fully clarified. Study for endolymphatic hydrops mainly represents a pathologic histologic finding found only in the post-mortem examination of temporal bone, so endolymphatic hydrops animal models have played important role in terms of understanding how hydrops affects the function of the inner ear. Numerous challenges with diverse animals and techniques have been tried to reveal the possible pathophysiology of endolymphatic hydrops and develop an effective treatment. This review shows historical background and technical advances in experimental animal model for endolymphatic hydrops and Meniere’s disease.

Original Article

Multicenter Randomized Study on the Efficacy of Isosorbide in Patients with Mèniére's Disease: Hyun Woo Park, Won Ho Chung, Sung Huhn Kim, Kyu Sung Kim, Jong Woo Chung, Sung Won Chae, Ja Won Koo, Bo Gyung Kim, Eui Kyung Goh, Gyu Cheol Han; Res Vestib Sci. 2016;15(2):44-50. Published online June 15, 2016

6,376 View
181 Download

Abstract PDF: Objective: Mèniére's disease is one of the most common causes of episodic vestibular syndrome that shows symptom complexes of recurrent vertigo, hearing loss, tinnitus and ear fullness. Isosorbide (Isobide) is a osmotic diuretics which has been used for Meniere's disease to reduce the endolymphatic pressure. The purpose of this study was to evaluate the efficacy of isosorbide in the treatment of Mèniére's disease by comparing the combined therapy of isosorbide and betahistine (Meniace) to betahistine only.
Methods
Among 220 patients enrolled with Mèniére's disease from 9 centers, 187 patients completed this clinical study. Patients were randomly subjected either to betahistine alone therapy at dose of 6 mg three times a day (n=97) or to combined therapy with isosorbide (dose of 30 mL three times a day) and betahistine (n=90) for 12 weeks. Two groups were compared at 4 and 12 weeks after treatment on frequency of vertigo, hearing level (pure tone audiometry, speech audiometry), electocochleography (ECoG), tinnitus (Tinnitus Handicap Inventory, THI) and quality of life (Korean functional level scale, Korean dizziness handicap inventory).
Results
During first 4 weeks after treatment, the frequency of vertigo was not reduced in either betahistine alone therapy group or combined therapy group. However, between 8 and 12 weeks, the frequency of vertigo was significantly reduced in either group, and in the combined group frequency of vertigo was more significantly reduced than in the betahistine alone therapy group (p=0.041). The hearing level, ECoG, tinnitus and quality of life was not significantly different between two groups.
Conclusion
Isosorbide and betahistine combined therapy were more effective for vertigo control than betahistine alone therapy. Isosorbide is an effective diuretic in vertigo control in definite Mèniére's disease.

Review

Clinical Applications of Vestibular Evoked Myogenic Potentials: Jeong Yoon Choi; Res Vestib Sci. 2015;14(2):37-41.

2,907 View
112 Download

Abstract PDF: Cervical and ocular vestibular evoked myogenic potential (VEMP) may be one of the important clinical tools for evaluation of vestibular function. Cervical VEMP evaluates saccule and reflects the functional status of inferior vestibular nerve combining with vertical head impulse test. Ocular VEMP assesses utricle function and provides superior vestibular nerve function in addition to horizontal head impulse test and caloric test. Currently, the clinical implications of VEMP have been expanded to estimate disease severity and location, differentiate diverse vestibular disorders, and predict the prognosis. In present review, we discuss the findings of VEMP according to the lesion location from peripheral vestibular dysfunction to central vestibulopathy and disease characteristics from monophasic transient disorders to chronic progressive disorders.

Case Reports

Profound Hearing Loss after Endolymphatic Sac Decompression in Intractable Meniere’s Disease: Pona Park, Kyung Tae Park, Hyun Seok Choi, Ja Won Koo; Res Vestib Sci. 2014;13(3):72-76.

2,980 View
39 Download

Abstract PDF: Endolymphatic sac decompression (ESD) is indicated in intractable Meniere’s disease patients with serviceable hearing. A 43-year-old man presented with recurrent vertigo and fluctuating right hearing loss that had been intractable to medical treatment. ESD was performed for the purpose of vertigo control with hearing preservation. Positional vertigo with profound hearing loss developed immediate after surgery and positional vertigo was resolved within days. Following paralytic vestibulopathy with positive sign on head thrust test also resolved after 2 weeks, while sensorineural hearing loss was not recovered to preoperative level during 1 year of follow up. Recurrent vertigo attacks were developed again 1 year after the operation. Hearing preservation was not always guaranteed in ESD. Furthermore, chance of hearing loss should be included in informed consent though the procedure is purposed for hearing preservation.

Cochleovestibular Otosclerosis Without Conductive Hearing Loss: Woo Sung Na, Sang Hyun Park, Chung Ku Rhee, Jae Yun Jung; Res Vestib Sci. 2013;12(1):22-26.

2,551 View
11 Download

Abstract PDF: Otosclerosis typically starts around stapes footplate presenting conductive hearing loss initially. However, otosclerosis may involve cochlea and vestibule causing sensorineural hearing loss and dizziness. We report a case of cochleovestibular otosclerosis without conductive hearing loss featuring Meniere’s disease.

Original Articles

Role of Endolymphatic Sac Decompression in Intractable Meniere’s Disease: Shin Hye Kim, Jihye Rhee, Yoonjong Ryu, Byung Yoon Choi, Ja Won Koo; Res Vestib Sci. 2013;12(1):16-21.

2,853 View
25 Download

Abstract PDF: Background and Objectives: The role of endolymphatic sac decompression (ELSD) for the treatment of intractable Meniere disease (MD) has been debated. However, considering few treatment options for medically intractable MD with serviceable hearing or intractable bilateral MD, ELSD has shown reasonable treatment results without ablating inner ear function. The aims of this study are to review the role of ELSD in the treatment of MD and clinical course and long-term outcome after ELSD. Materials and Methods: The ELSD was performed in 7 patients among 603 definite Meniere disease patients between May 2003 and December 2010. Patient’s medical history and clinical courses after surgery were obtained by medical record review and telephone interview. Results: Mean duration of follow up until receiving ELSD was 575 days since initial visit. Six patients showed complete control or substantial control of vertigo, but one patient suffered from sustained vertigo attacks even after ELSD, the vertigo was controlled after intratympanic gentamicin injection (ITGI) at 20 months after ELSD. Another patient had recurrence of vertigo after 30 months, which was successfully controlled by ITGI. The preoperatively mean monthly vertigo was 4.8 and it was significantly decreased to 1.5 after postoperatively 1 year, 0 after postoperatively 2 years (p<0.001). Hearing was preserved in 6 patients during the follow-up period. Conclusion: Most patients who were uncontrolled vertigo with 3 to 6 months medication showed significantly reduced vertigo and hearing preservation after ELSD. The ELSD seems to be a beneficial treatment option for intractable MD.

Diagnostic Value of Cochlear Hydrops Analysis Masking Procedure in Meniere's Disease in Comparison with Electrocochleography: Ju Sang Lee, Eun Sun Park, Sung Kwang Hong, Jung Hak Lee, Hyo Jeong Lee, Hyung Jong Kim; Res Vestib Sci. 2011;10(1):19-25.

3,817 View
67 Download

Abstract PDF: Background and Objectives: Patients with Meniere’s disease often present with a great variety of symptoms, especially at the onset of the disease. However, there is no single test that is definitive for making the diagnosis of Meniere’s disease. Recently, a new diagnostic test, the cochlear hydrops analysis masking procedure (CHAMP) was introduced as a test for endolymphatic hydrops. The aim of this study is to evaluate the diagnostic value of CHAMP test in Meniere’s disease in comparison with that of electrocochleography. Materials and Methods: The CHAMP test and electrocochleography were simultaneously performed in 14 cases of definite Meniere’s disease and 8 normal healthy volunteers (16 ears). Positive criteria were defined as being more than 0.35 in summating potential/action potential (SP/AP) ratio, 0.3 ms or less in latency delay and 0.95 or less in complex amplitude ratio. Measured parameters from each test were compared between the groups, and sensitivity and specificity of each test in diagnosing Meniere’s disease were calculated. Results: There was no significant difference in the SP/AP ratio of electrocochleography between the Meniere’s disease and control groups. In CHAMPtest, the latency delay was shorter and the complex amplitude ratio was smaller (p<0.001). While taking positive results from both test parameters, the sensitivity and specificity of CHAMP test were 85.7% and 87.5%, respectively. Conclusion: The CHAMP seems to be a clinically useful tool in diagnosing Meniere’s disease and might be better than electrocochleography to detect endolymphatic hydrops.

Case Report

Periodic Alternating Nystagmus in Vestibulocochlear Disorder: Seong Hae Jeong, Eung Seok Oh, Ji Hee Lee, Jae Moon Kim; Res Vestib Sci. 2009;8(1):49-51.

2,260 View
14 Download

Abstract PDF: Periodic alternating nystagmus (PAN) is characterized by horizontal nystagmus that reverses direction periodically. PAN can occur in both congenital and acquired conditions. We report a 58-year old man with peripheral vertigo and hearing impairment showing PAN in darkness. Key Words: Vertigo; Hearing loss; Nystagmus, Pathologic; Meniere Disease

Original Article

Effect of Intratympanic Chemical Labyrinthectomy with Streptomycin on Auditory Symptoms: Hyun Su Kim, Sung Huhn Kim, Dae Bo Shim, Sang Cheol Kim, Won Sun Yang; Res Vestib Sci. 2009;8(1):32-36.

2,623 View
17 Download

Abstract PDF: Background and Objectives Background and Objectives: Intratympanic treatment with aminoglycosides for Ménière’s disease has been used, trying to eliminate vertigo complaints, while preserving hearing. This study was undertaken to evaluate the therapeutic outcomes for auditory symptoms in Ménière’s disease patients after intratympanic application with single low-dose streptomycin powder. Materials and Methods Ninty-eight patients diagnosed with definite Ménière’s disease who underwent chemical labyrinthectomy with streptomycin at Yonsei University Medical Center from March 1997 to June 2006 were enrolled. Low dose streptomycin powder (10 mg) was applied into the round window niche directly. Changes of hearing threshold, tinnitus and aural fullness were evaluated postoperatively according to Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease of American Academy of Otolaryngology–Head and Neck Surgery. Results Hearing threshold was not changed significantly after the procedure (from 65.5±19.1 to 69.3±20.0 p>0.05) and was improved in 7% of the patients. Hearing deterioration after the procedure was detected only in 17%. Tinnitus and aural fullness was improved in 51% and 25% respectively. Conclusion Single application of streptomycin powder filling round window niche showed minimal deterioration of hearing threshold. It is the useful method to improve or prevent the progress of auditory symptoms in patients with Ménière’s disease. Key Words: Streptomycin; Hearing loss; Tinnitus; Meniere Disease; Aural fullness

First
Prev
Page of 1
Next
Last

Search